Halaman 4 - Kanker esofagus Dokter Terbaik - TOP-134 dokter

Associate Professor Tahsin Ozatli berspesialisasi dalam kanker payudara, paru-paru, dan gastrointestinal di Rumah Sakit Universitas Istinye Liv.

• Memiliki pengalaman lebih dari 10 tahun di bidang onkologi
• Berspesialisasi dalam kanker gastrointestinal termasuk kanker kerongkongan
• Dipromosikan menjadi Associate Professor pada tahun 2016
• Menempuh pendidikan di Fakultas Kedokteran Universitas Selçuk

Dr. Muzaffer Al berspesialisasi dalam bedah laparoskopi tingkat lanjut dan bedah kanker onkologi, dengan pelatihan ekstensif di institusi medis ternama.

• Terlatih dalam bedah laparoskopi di Fakultas Kedokteran Çapa Universitas Istanbul
• Berspesialisasi dalam bedah antirefluks laparoskopi dan bedah bariatrik laparoskopi tingkat lanjut
• Memiliki pengalaman dalam bedah kanker onkologi, termasuk kanker esofagus

Profesor Gul Alco adalah spesialis onkologi radiasi dengan pengalaman lebih dari 20 tahun, saat ini bertugas di Universitas Medipol Istanbul.

• Menyelesaikan pendidikan di Universitas Istanbul dan Universitas Kadir Has
• Menjabat sebagai Lektor Kepala dan kemudian Profesor di Universitas Demiroglu Bilim
• Ahli dalam onkologi radiasi untuk pengobatan kanker
• Bekerja di Rumah Sakit Distrik Medipol Acibadem

Assoc. Prof. Nail Paksoy berspesialisasi dalam pengobatan kanker kerongkongan di Rumah Sakit Medipol Bahçelievler, dengan pengalaman penelitian dan uji klinis yang luas.

• Tersertifikasi Dewan ESMO dalam Onkologi Medis
• Berpartisipasi dalam 8 uji klinis internasional untuk berbagai jenis kanker
• Menerbitkan berbagai studi tentang hasil pengobatan kanker
• Menyelesaikan pelatihan fellowship di Institut Onkologi Universitas Istanbul

30+ tahun di bidang imunologi dengan fokus pada viroterapi – Dr. Jaunalksne menghadirkan keahlian imunoterapi mutakhir untuk pengobatan kanker esofagus.

• Spesialisasi dalam viroterapi, sebuah pendekatan baru untuk pengobatan kanker
• Memimpin Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins
• Lulus dari Institut Medis Riga

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Auala Hubert memimpin Pusat Kanker Gastrointestinal di Hadassah Medical Center, membawa 33 tahun keahlian onkologi terfokus.

• Spesialisasi dalam onkologi medis dan radioterapi untuk kanker esofagus
• Kepala Pusat Kanker Gastrointestinal di Rumah Sakit Universitas Hadassah
• Sertifikasi dewan dalam onkologi dan radioterapi dengan kualifikasi USMLE
• Anggota aktif Masyarakat Onkologi Klinis Israel dan Asosiasi Kanker

Dr. Ozden spesialis dalam pengobatan kanker esofagus dengan pelatihan ekstensif di bidang onkologi medis.

• Lulus dari Fakultas Kedokteran Cerrahpaşa Universitas Istanbul
• Menyelesaikan subspesialisasi onkologi medis di Universitas Kocaeli
• Pengalaman lebih dari satu dekade di bidang penyakit dalam dan onkologi
• Praktik di Rumah Sakit VM Medical Park Pendik

Dr. Alemdar berspesialisasi dalam pengobatan kanker kerongkongan, dengan pelatihan ekstensif di Rumah Sakit Universitas Akdeniz – pusat onkologi utama.

• Tersertifikasi dalam onkologi medis sejak 2018
• Pengalaman lebih dari 12 tahun di bidang onkologi medis
• Anggota Masyarakat Onkologi Medis Turki
• Praktik di Kompleks Rumah Sakit Medical Park Antalya – sebuah fasilitas terakreditasi JCI

Direktur Residensi Bedah di Hadassah Medical Center, melatih generasi ahli bedah berikutnya dalam prosedur kompleks. Beliau telah menjadi dosen senior bedah selama hampir dua dekade.

• Pengalaman lebih dari 35 tahun di bidang bedah dan spesialisasi kolorektal
• Instruktur bedah di rumah sakit universitas besar sejak 1995
• Tersertifikasi dewan dalam bedah umum sejak 1998
• Anggota aktif di berbagai asosiasi bedah
• Lancar berbahasa Inggris dan Ibrani untuk pasien internasional

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.